Search Criteria : United States of America
Nov 04, 2019 - Oct 31, 2020 | CME 77.75 | USD $12,900.00 | Boston, Massachusetts
High-Impact Cancer Research Program is organized by Harvard Medical School (HMS). This Onsite medical conference will be held from Nov 04, 2019 - Oct 31, 2020, at Harvard Medical School, Boston, Massachusetts, United States of America. Who Should Apply: This Harvard Medical School program is open to both new and seasoned researchers including professionals in fundamental and clinical research, population health leaders of cancer-focused enterprises including scientific, policy, and financial top-flight trainees. Prospective students should hold a master’s degree in their field of study, a doctoral degree such as Ph.D., or PsyD and/or a professional degree such as an MD, MBBS, DDM, DMD, PharmD, DNP or foreign equivalent degree. What is the credit statement of the High-Impact Cancer Research Program? Accreditation: The Harvard Medical School is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to present continuing medical education for physicians. This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 7.25 credits of Risk Management Study. Live Workshops: The Harvard Medical School designates this live activity for a maximum of 77.75 AMA PRA Category 1 Credits™. Physicians will be able to earn only the credit commensurate with the extent of their participation in the activity. Online Modules: The Harvard Medical School designates this enduring material for a maximum of 52.50 AMA PRA Category 1 Credits™. Physicians will be granted the credit commensurate with the extent of their participation in the activity. What is the significance of the High-Impact Cancer Research Program? Conference Overview: With so many new and promising strategies and recent developments, the opportunities to produce and enable high-impact cancer research are unprecedented. Recent advances continue to expand and reshape our views of the essential features of cancer. We are learning important new aspects of how cancers develop, how to find and diagnose cancers earlier, how to design and unleash powerful new anti-cancer therapies, and how to evaluate cancer risk and even prevent tumors from arising. These advances are delivering useful, productive changes that lead to better cancer outcomes. High-Impact Cancer Research is the acclaimed Harvard Medical School postgraduate certificate program for cancer research. It teaches the principles and skills shaping today’s most important cancer research activities. High-Impact Cancer Research faculty are distinguished leading experts who have achieved breakthroughs in fields from discovery biology to therapeutics and prevention. In this special program, world leaders in cancer research share their insights and teach this changing science. Participants learn the new fundamentals of a wide spectrum of cancer science and the skills necessary to envision, design, and lead cutting-edge cancer research projects that can contribute to these changes. What are the objectives of the High-Impact Cancer Research Program? Conference Objectives: This program is intended to help participants make high-impact contributions that manage to better cancer outcomes. Upon completion of the program, participants will be able to: • Explain the molecular and cellular basis of cancer development, detection, diagnosis, treatment, and prevention • Read about important advances within the context of clinical presentation of various human tumors and ways it is currently being used to develop the growing set of therapeutic and preventive approaches to fighting cancer • Discover about distinct cancer treatments from the individuals who developed the therapies and are testing them in ongoing clinical trials • Hone skills necessary to identify and answer key questions needed to make future contributions and to effectively communicate your ideas and conclusions • Earn critical skills to interpret and assess emerging cancer research • Envision and design cancer research projects • Improve writing skills for personal career advancement (e.g., grant applications or funding requests; the science section of a business plan designed to highlight a particular commercial opportunity; papers suitable for submission and publication) • Form an international network of colleagues and work effectively with international peers Curriculum Highlights This program allows participants to learn directly from Harvard’s leading faculty in discovery biology and clinical tumor development, and from internationally recognized leaders in the cancer research community who have achieved breakthroughs in therapeutics, risk assessment, and prevention. Peer-to-peer learning projects allow participants to learn from one another while producing publication-quality reports on important aspects of cancer research. This also allows each participant to develop a large network of international colleagues who will be resources throughout their career. Students can also customize their learning experience and skills development around their interests and career goals through two optional elective tracks (Communications or Leadership and Management) and an education track for deeper immersion into one of four areas: • Cancer -Omics • Clinically challenging cancers • Risk and prevention • Therapeutic development • Three workshops hosted at Harvard Medical School (Boston, MA): Workshop Dates: • Workshop 1: November 4 – 8, 2019 (Boston) • Workshop 2: April 14 – 18, 2020 (Boston) • Workshop 3: October 26 – 31, 2020 (Boston).
Humanities in Medicine 2021 Course is organized by Mayo Clinic and will be held from Sep 17 - 19, 2020 at Mayo Clinic, Rochester, Massachusetts, United States of America. Description: The annual gathering showcases research and best practice surrounding the intersection of arts and humanities disciplines with a connection to healthcare – inclusive of music, visual art, theater, dance, creative writing, storytelling, narrative practice, ethical considerations, and other topical discussions. Learning Objectives: Attendance at any Mayo Clinic course does not indicate or guarantee competence or proficiency in the skills, knowledge or performance of any care or procedure(s) which may be discussed or taught in this course. Additional details will be posted as soon as information is available.
Sep 21 - 23, 2020 | USD $2,760.00 | Boston, Massachusetts
Measurement, Design, and Analysis Methods for Health Outcomes Research is organized by Harvard T.H. Chan School of Public Health Executive and Continuing Professional Education (ECPE) and will be held from Sep 21 - 23, 2020 at Harvard T.H. Chan School of Public Health, Boston, Massachusetts, United States of America. Who Should Participate: This program will be useful to anyone involved in improving health care cost, quality, or outcomes from across the health care industry. Ideal participants include: • Clinicians, including physicians, nurses, and allied health professionals involved in utilizing outcomes data or assessing, measuring, and evaluating outcomes • Health care executives and administrators who review and utilize outcomes data for clinical decision-making and improving quality of care • Insurance, managed care, and other payer executives and researchers seeking to understand the relative value of procedures and interventions • Pharmaceutical and biotechnology executives and researchers who need to measure patient-reported outcomes to support the benefit of their products • Other health sector researchers who are new to outcomes research and need an overview of the latest information in the field Program Overview: Health care systems around the world are facing growing pressures to provide more effective care at lower costs. Health outcomes research assesses the end results of health care services, providing evidence for the value of specific medical treatments or interventions that can be used to make better decisions and improve health care. Measurement, Design, and Analysis Methods for Health Outcomes Research provides you with the language and concepts you need to synthesize outcomes studies into useful knowledge for effective clinical and business decision-making. You will learn to design, implement, critically review, and analyze health outcomes studies and gain an understanding of the statistical methods required for outcomes research. This program explores many aspects of health outcomes research, including: • Designing health outcomes research studies • Data collection considerations • Measurement and evaluation of outcomes data • Analysis and applications of studies Program Objectives As a participant, you will learn to: • Evaluate the usefulness of outcomes measures and the application of new technologies in organizations • Conceptually define the meaning and purpose of outcomes research • Understand the role of epidemiology, health economics, psychometrics and biostatistics in conducting outcomes research • Recognize the different types of measures used in outcomes research, including clinical, health status, quality of life, work/role performance, health care utilization, and patient satisfaction • Adopt new methods for modeling patient responses • Interpret statistical measurement concepts such as reliability, validity, responsiveness, sensitivity, and power • Understand statistical analysis appropriate for outcomes research, including analysis of longitudinal and categorical data • Synthesize findings from a variety of health outcomes research studies • Compare the effectiveness of different treatments for the same illness
Sep 21, 2020 | Boston, Massachusetts
Mobile in Clinical Trials is organized by The Conference Forum (TCF) and will be held on Sep 21, 2020 at The Westin Copley Place, Boston, Boston, Massachusetts, United States of America. Additional details will be posted as soon as information is available.
Sep 22 - 23, 2020 | USD $250.00 | Palmer, Massachusetts
Advanced Cardiovascular Life Support (ACLS) Course s organized by Baystate Health and will be held from Sep 22 - 23, 2020 at Baystate Wing Hospital Griswold Center, Palmer, Massachusetts, United States of America. Course Description: ACLS is an advanced, Instructor-led classroom course that highlights the importance of: • team dynamics and communication • systems of care and immediate post-cardiac arrest care • airway management • related pharmacology In this course, skills are taught in large, group sessions and small, group learning and testing stations where case-based scenarios are presented. ACLS is designed for Medical professionals who respond to cardiovascular emergencies in and out of the hospital. To enhance their treatment knowledge and skills through the AHA’s ACLS training courses. Additional details will be posted as soon as information is available.
Sep 25 - 27, 2020 | USD $795.00 | Boston, Massachusetts
Practical Approach to Electromyography and Neuromuscular Disorders is organized by Boston University School of Medicine Continuing Medical Education/Continuing Nursing Education (BUSM CME/CNE) and will be held from Sep 25 - 27, 2020 at Revere Hotel Boston Common, Boston, Massachusetts, United States of America. Additional details will be posted as soon as information is available.
Sep 26 - 27, 2020 | Contact Hours 15 | USD $545.00 | South Weymouth, Massachusetts
The NeuroVestibular Complex is organized by Therapy Network Seminars (TNS) and will be held from Sep 26 - 27,2020 at South Shore Hospital, South Weymouth, Massachusetts, United States of America. Target Audience: This course is intended for PTs, PTAs, OTs, OTAs and ATs Educational Credit: A certificate of attendance for 15 Contact Hourswill be awarded to each participant. All Therapy Network Seminars are pre‐approved for CEUs in the state where the course is conducted when required for PT, OT, ATs & Assistants. Seminar Description: This hands-on course is designed to bridge the gap between evaluation and treatment of adult patients with balance disorders associated with vestibular dysfunction. A structured method of examination involving the components of movement and mobility will be presented in conjunction with treatment paradigms specific to the diagnosis and impairments. Functional testing procedures and evidenced-based treatment techniques will be demonstrated and reinforced with hands on practice time to allow for integration of the material. All course materials have been carefully designed to serve as a life long resource in the clinic. Objectives: • Identify anatomy and pathophysiology as it relates to balance control • Describe the factors that make the older adult more prone to falls • Differentiate the patient report of dizziness into one of three possible etiologies: vestibular dysfunction, disequilibrium, or non-vestibular dysfunction • Identify non-vestibular causes for dizziness and possible treatment options • Demonstrate skill in the use of the (1) special vestibular tests, (2) motion sensitivity tests and (3) standardized balance and mobility tests presented in this seminar • Perform a detailed subjective/objective evaluation of the patient who presents with balance dysfunction or dizziness Additional details will be posted as soon as information is available.
Sep 27 - Oct 04, 2020 | CME 14 | USD $895.00 | Boston, Massachusetts
PLEASE NOTE: THIS IS NOT A CURRENTLY ACTIVE PROGRAM. Pain Management & Endocrinology is organized by Continuing Education, Inc. and will be held from Sep 27 - Oct 04, 2020 at Royal Caribbean's Brilliance of the Seas, Boston, Massachusetts, United States of America. Target Audience: Physicians, Physician Assistants, Nurses, Nurse Practitioners, Pharmacists Accreditation: • 14 AMA PRA Category 1 Credits™ • 14 ACPE Credits • 14.0 Contact Hours • 10 ¾ Hours of Pharmacology for NPs Program Purpose: The purpose of these lectures is to provide an overview of the management of common endocrinology problems utilizing new guidelines and medications to improve the care of patients seen in primary care settings. Areas covered include: thyroid disorders and the effectiveness of dietary, surgical and medical therapy for obesity. New guidelines have been published by the American College of Cardiology for the management of lipid disorders and cases will be used to illustrate their effective use. Comfortable use of the diagnostic tests and medications for metabolic bone problems is another goal. An approach to the integration of new diabetes medications into primary care practice and the American Diabetes Association guideline changes for 2020 will be discussed to improve understanding of their utility in various types of patients particularly those with complications from diabetes. Advances in the diagnosis and management of common pituitary and adrenal disorders have recently changed with new guidelines from the Endocrine Society. It is estimated that more than 100 million adults in the United States experience chronic pain and that over 20 million experience moderate to severe also known as "high impact" chronic pain. It is therefore not surprising that pain is the most common reason for a person to visit a health care provider. We will cover key timely topics in pain management focused and enabling the participant to become more comfortable with the assessment and treatment of various chronic pain conditions. Topics: • Nutritional, Medical and Surgical Management of Obesity ○ Discuss the use of appropriate food plans and medications and selection of surgical procedures that will benefit particular patients • Management of Thyroid Disease ○ Discuss populations that should be screened for thyroid disease • Metabolic bone disease: When and How to Treat ○ Recognize when patients should start and stop bisphosphonate therapy. • Using Insulin Effectively in the Treatment of Type 1 and Type 2 Diabetes ○ Design appropriate insulin therapy for various types of patients • Selecting the Best Medications for Your Patient with Type 2 Diabetes ○ Discuss the place of various oral agents and new injectables in the management of Type 2 diabetes • Management of Dyslipidemia: New Guidelines ○ Discuss new guidelines for the management lipid disorders • Spotting adrenal and pituitary problems in your practice ○ Recognize primary and secondary adrenal insufficiency and prolactinomas • Managing Headache Does Not Have to Be a Headache ○ Identify and treat common headache disorders • Interventional Pain Management for the Non-Pain Specialist ○ Identify common interventional pain management treatments and recognize when a referral should be made for these • Is it Ever Appropriate to Prescribe Opioids on a Long-Term Basis for Non-Cancer Pain? ○ Better understand the role of chronic opioid therapy for chronic non-cancer pain • How Do I Taper My Patient from Opioid Therapy? ○ Institute a rational approach to tapering opioid therapy when appropriate • Chronic Musculoskeletal Pain ○ Identify and treat common musculoskeletal conditions associated with chronic pain • Established and Emerging Treatments for Neuropathic Pain ○ To identify common neuropathic pain conditions and institute treatment for these • An Overview of Non-Opioid Pharmacotherapy for Acute and Chronic Pain ○ To identify common classes of non-opioid medications for chronic pain and to be able to utilize these for treatment Conference Sessions generally take place on days at sea (as itinerary allows), giving you plenty of time to enjoy your meals, evenings and ports of call with your companion, family and friends.
Sep 29, 2020 | USD $60.00 | Palmer, Massachusetts
Basic Life Support (BLS) for Healthcare Providers Course is organized by Baystate Health and will be held on Sep 29, 2020 at Baystate Wing Hospital Griswold Center, Palmer, Massachusetts, United States of America. Course Description: Basic Life Support for Healthcare Providers is for both new certifications and renewals. This course covers: • Adult, child, and infant CPR/AED • Single and multiple rescuers CPR/AED • Airway management, including bag-mask and rescue breathing • Team dynamics for both in and out of hospital care • Recognition of life-threatening emergencies, including choking The goal of this course is to provide you the ability to recognize several life-threatening emergencies, provide CPR, use an AED and relieve choking in a safe, timely and effective manner. Additional details will be posted as soon as information is available.
Oct 02 - 05, 2020 | CME 17.25 | Boston, Massachusetts
Myeloma and Plasma Cell Dyscrasias Course is organized by American Association for Cancer Research (AACR) and will be held from Oct 02 - 05, 2020 at The Westin Copley Place, Boston, Boston, Massachusetts, United States of America. Accreditation: AACR has designated this live activity for a maximum of 17.25 AMA PRA Category 1 Credit(s)™. Physicians should only claim credit commensurate with the extent of their participation in the activity. Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.25 Medical Knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit. Description: The research being presented at this conference will address some of the needs mentioned above. The program was designed to discuss advances in basic and translational research (genetics, risk assessment of precursor conditions, monitoring, drug resistance, etc.) and evaluate their application to improve clinical outcomes. Learning Objectives: After participating in this CME activity, physicians should be able to: • Explain the spectrum of precursor conditions and evaluate their risk of progression to myeloma. • Provide examples of current technologies to diagnose and monitor myeloma and precursor conditions. • Provide examples of the latest research in myeloma genetics and the study of the myeloma microenvironment. • Identify current therapeutic options to treat myeloma, including combination therapies and immunotherapeutics. • Articulate various mechanisms of drug resistance and therapeutic evasion. Additional details will be posted as soon as information is available.